The creation of the FARE Clinical Network seeks to address key challenges in research and patient care, and the addition of UCLA Health and the University of Michigan adds to the strength of this national collaborative effort.
McLean, VA (PRWEB) November 12, 2015
Food Allergy Research & Education (FARE), the leading nonprofit organization working on behalf of the 15 million Americans with food allergies, announced today the addition of UCLA Health and University of Michigan to the FARE Clinical Network, a revolutionary food allergy research collaborative that aims to accelerate the development of drugs for patients with food allergies and improve the quality of care for this serious illness.
Launched earlier this year, the FARE Clinical Network comprises 24 leading research and care sites nationwide and represents an investment by FARE of more than $2.5 million annually. Under FARE’s leadership and coordination, FARE Clinical Network members will serve as sites for clinical trials for the development of new therapeutics and will develop best practices for the care of patients with food allergies. The FARE Clinical Network will serve as a powerful driver of collaboration to advance the field of food allergy, with member centers contributing to the development of a national food allergy patient registry and biorepositories. FARE plans to further expand the network within the next three years.
“Food allergy research has been under-funded and the field has lacked the infrastructure needed to conduct late-stage clinical trials for promising therapies, which are critical for evaluating potentially life-changing treatments,” said Mary Jane Marchisotto, senior vice president of research and operations of FARE. “The creation of the FARE Clinical Network seeks to address key challenges in research and patient care, and the addition of UCLA Health and the University of Michigan adds to the strength of this national collaborative effort.”
Members of the FARE Clinical Network are selected through a comprehensive, rigorous application process. Centers are required to address criteria in a number of key areas, including staff credentials, statements regarding their implementation of state-of-the-art diagnostic and clinical practice guidelines and information about their facilities, operational oversight, training, patient satisfaction surveys and quality of life data.
The centers of excellence selected as part of the FARE Clinical Network provide high-quality clinical and sub-specialty food allergy expertise and services, and are focused on applying new evidence-based knowledge to this important field. These centers also meet high standards for clinical care, teaching and clinical research.
FARE is pleased to make information about FARE Clinical Network members available to supporters and families managing food allergies. FARE recommends that patients managing food allergies meet with their physicians to discuss their individual needs in order to inform their personal healthcare decisions.
To view a list of other centers of excellence and for more information, visit http://www.foodallergy.org/research/fare-clinical-network.